ACRUX Ltd (ACR) - Total Liabilities

Latest as of June 2025: AU$6.20 Million AUD ≈ $4.39 Million USD

Based on the latest financial reports, ACRUX Ltd (ACR) has total liabilities worth AU$6.20 Million AUD (≈ $4.39 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

ACRUX Ltd - Total Liabilities Trend (2001–2025)

This chart illustrates how ACRUX Ltd's total liabilities have evolved over time, based on quarterly financial data. See ACRUX Ltd (ACR) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

ACRUX Ltd Competitors by Total Liabilities

The table below lists competitors of ACRUX Ltd ranked by their total liabilities.

Company Country Total Liabilities
Fairchild Gold Corp
V:FAIR
Canada CA$504.25K
Noroo Holdings Co Ltd
KO:000325
Korea ₩486.98 Billion
Cerillion PLC
LSE:CER
UK GBX15.66 Million
IDOX plc
LSE:IDOX
UK GBX71.48 Million
Simble Solutions Ltd
AU:SIS
Australia AU$1.22 Million
Askari Metals Ltd
AU:AS2
Australia AU$1.62 Million
OMG Group Ltd
AU:OMG
Australia AU$3.08 Million
DRAGO ENTERTAINM. ZY -10
F:65M
Germany €2.25 Million

Liability Composition Analysis (2001–2025)

This chart breaks down ACRUX Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ACR stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.07 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.19 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 6.06 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.86 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ACRUX Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ACRUX Ltd (2001–2025)

The table below shows the annual total liabilities of ACRUX Ltd from 2001 to 2025.

Year Total Liabilities Change
2025-06-30 AU$6.20 Million
≈ $4.39 Million
+9.06%
2024-06-30 AU$5.69 Million
≈ $4.02 Million
+1.50%
2023-06-30 AU$5.60 Million
≈ $3.96 Million
-9.38%
2022-06-30 AU$6.18 Million
≈ $4.37 Million
+7.89%
2021-06-30 AU$5.73 Million
≈ $4.06 Million
+1.04%
2020-06-30 AU$5.67 Million
≈ $4.01 Million
+127.15%
2019-06-30 AU$2.50 Million
≈ $1.77 Million
-0.87%
2018-06-30 AU$2.52 Million
≈ $1.78 Million
-25.50%
2017-06-30 AU$3.38 Million
≈ $2.39 Million
-64.34%
2016-06-30 AU$9.48 Million
≈ $6.71 Million
+20.48%
2015-06-30 AU$7.87 Million
≈ $5.57 Million
-29.51%
2014-06-30 AU$11.16 Million
≈ $7.90 Million
+81.76%
2013-06-30 AU$6.14 Million
≈ $4.35 Million
+13.83%
2012-06-30 AU$5.40 Million
≈ $3.82 Million
-59.38%
2011-06-30 AU$13.28 Million
≈ $9.40 Million
+323.57%
2010-06-30 AU$3.14 Million
≈ $2.22 Million
-15.86%
2009-06-30 AU$3.73 Million
≈ $2.64 Million
+18.02%
2008-06-30 AU$3.16 Million
≈ $2.23 Million
+48.75%
2007-06-30 AU$2.12 Million
≈ $1.50 Million
-19.92%
2006-06-30 AU$2.65 Million
≈ $1.88 Million
+64.47%
2005-06-30 AU$1.61 Million
≈ $1.14 Million
+19.52%
2004-06-30 AU$1.35 Million
≈ $954.23K
+14.18%
2003-06-30 AU$1.18 Million
≈ $835.75K
+35.69%
2002-06-30 AU$870.46K
≈ $615.91K
+17.47%
2001-06-30 AU$741.00K
≈ $524.30K
--

About ACRUX Ltd

AU:ACR Australia Biotechnology
Market Cap
$4.36 Million
AU$6.16 Million AUD
Market Cap Rank
#28807 Global
#1584 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.02
All Time High
AU$0.83
About

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for th… Read more